ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.839,03
-1,15%
S&P 500
5.719,66
-0,99%
Dow Jones
42.503,64
-0,20%
Euro vs US Dollar
1,07887
0,02%
Bitcoin
86.717,69
-0,86%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. AbCellera Biologics Inc (ABCL) Börsenkurse

AbCellera Biologics Inc

AbCellera Biologics Inc (ABCL)

NASDAQ
2,435
-0,095
( -3,75% )
Aktualisiert: 17:53:28
Verzögert um 15 Minuten
Fortg. Diagramm

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
2,435
Gebot
2,43
Fragen
2,44
Volumen
1.477.731
2,41 Tagesbereich 2,53
2,11 52-Wochen-Bereich 4,7499
Marktkapitalisierung
717,511M
Handelsende
2,53
Handelsbeginn
2,53
Letzte Trade
64
@
2.43
Letzter Handelszeitpunkt
17:53:52
Finanzvolumen
US$ 3.635.049
VWAP
2,4599
Durchschnittliches Volumen (3 Mio.)
4.170.240
Ausgegebene Aktien
294.665.532
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-4,40
Gewinn pro Aktie (EPS)
-0,55
Erlöse
28,83M
Nettogewinn
-162,86M

Über AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners. AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Sektor
Medicinal Chems,botanicl Pds
Branche
Medicinal Chems,botanicl Pds
Website
investors.abcellera.com/overview/default.aspx
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
-
AbCellera Biologics Inc is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker ABCL. The last closing price for AbCellera Biologics was US$2,53. Over the last year, AbCellera Biologics shares have traded in a share price range of US$ 2,11 to US$ 4,7499.

AbCellera Biologics currently has 294.665.532 shares in issue. The market capitalisation of AbCellera Biologics is US$745,50 million. AbCellera Biologics has a price to earnings ratio (PE ratio) of -4.40.

ABCL Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
11 März 2025
ABCL (-3,75%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
10 März 2025
ABCL (-3,75%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 März 2025
ABCL (-3,75%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
27 Februar 2025
ABCL (-3,75%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
27 Februar 2025
ABCL (-3,75%)

Form 8-K - Current report
Edgar (US Regulatory)
27 Februar 2025
ABCL (-3,75%)

Form 8-K - Current report
Edgar (US Regulatory)
18 Februar 2025
ABCL (-3,75%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.1054.506437768242.332.62.3235235372.46281585CS
4-0.42-14.7110332752.8553.0052.1143842282.459448CS
12-0.525-17.73648648652.963.682.1141702402.90063875CS
26-0.045-1.814516129032.483.682.1131364812.8658195CS
52-2.205-47.52155172414.644.74992.1123860172.97711123CS
156-7.035-74.28722280899.4714.972.1121234826.17784588CS
260-58.565-96.00819672136171.912.1120195509.93954203CS

ABCL - Frequently Asked Questions (FAQ)

What is the current AbCellera Biologics share price?
The current share price of AbCellera Biologics is US$ 2,435
How many AbCellera Biologics shares are in issue?
AbCellera Biologics has 294.665.532 shares in issue
What is the market cap of AbCellera Biologics?
The market capitalisation of AbCellera Biologics is USD 745,5M
What is the 1 year trading range for AbCellera Biologics share price?
AbCellera Biologics has traded in the range of US$ 2,11 to US$ 4,7499 during the past year
What is the PE ratio of AbCellera Biologics?
The price to earnings ratio of AbCellera Biologics is -4,4
What is the cash to sales ratio of AbCellera Biologics?
The cash to sales ratio of AbCellera Biologics is 24,85
What is the reporting currency for AbCellera Biologics?
AbCellera Biologics reports financial results in USD
What is the latest annual turnover for AbCellera Biologics?
The latest annual turnover of AbCellera Biologics is USD 28,83M
What is the latest annual profit for AbCellera Biologics?
The latest annual profit of AbCellera Biologics is USD -162,86M
What is the registered address of AbCellera Biologics?
The registered address for AbCellera Biologics is 150 W 4TH AVENUE, VANCOUVER, BRITISH COLUMBIA, V5Y 1G6
What is the AbCellera Biologics website address?
The website address for AbCellera Biologics is investors.abcellera.com/overview/default.aspx
Which industry sector does AbCellera Biologics operate in?
AbCellera Biologics operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PTPIPetros Pharmaceuticals Inc
US$ 0,20005
(246,11%)
1,28B
OSRHOSR Holdings Inc
US$ 3,35
(109,38%)
71,22M
VVPRVivoPower International PLC
US$ 4,145
(83,41%)
126,85M
OCEAOcean Biomedical Inc
US$ 0,102
(79,58%)
395,22M
SURGSurgePays Inc
US$ 2,212
(60,29%)
62,54M
BACKIMAC Holdings Inc
US$ 0,085
(-57,50%)
1,11M
ACRVAcrivon Therapeutics Inc
US$ 3,2988
(-38,80%)
880,89k
TNONTenon Medical Inc
US$ 2,52
(-32,80%)
15,9M
BHILBenson Hill Inc
US$ 0,2925
(-30,92%)
667,67k
HUMAHumacyte Inc
US$ 2,0337
(-29,26%)
15,72M
PTPIPetros Pharmaceuticals Inc
US$ 0,20005
(246,11%)
1,28B
OCEAOcean Biomedical Inc
US$ 0,102
(79,58%)
395,22M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,06955
(37,45%)
186,45M
NVDANVIDIA Corporation
US$ 113,9292
(-5,60%)
166,11M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,613
(-10,44%)
140,73M

ABCL Finanzen

Finanzen

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
ABCL
AbCellera Biologics
NASDAQ
IDCC
InterDigital
NASDAQ
ODFL
Old Dominion Freight Line
EU
AF
Air FranceKLM
DOWI
DJEEOT
DJ Emerging Markets Oil ...
TSXV
RUN.H
Running Fox Resource
DOWI
DJUSRS
DJ US Specialty Retailers
USOTC
ATPMF
Antipa Minerals (PK)
NASDAQ
TLRY
Tilray Brands
EU
DG
Vinci
DOWI
DJNAJO
DJ North America Select ...
NASDAQ
TRSG
Tungray Technologies
NASDAQ
PXLW
Pixelworks
DOWI
DJCIHG
DJ Commodity Index North...
NYSE
ADCT
ADC Therapeutics
NASDAQ
TTEK
Tetra Tech
Delayed Upgrade Clock
ADVFN Logo
Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten